Bio-Connect

CDC2L5 antibody

GTX102408
GeneTex
ApplicationsWestern Blot
Product group Antibodies
ReactivityHuman
TargetCDK13
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CDC2L5 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.83 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID8621
  • Target name
    CDK13
  • Target description
    cyclin dependent kinase 13
  • Target synonyms
    CDC2L; CDC2L5; CDC2-related protein kinase 5; cell division cycle 2-like protein kinase 5; cell division protein kinase 13; CHDFIDD; CHED; cholinesterase-related cell division controller; cyclin-dependent kinase 13; hCDK13
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ14004
  • Protein Name
    Cyclin-dependent kinase 13
  • Scientific Description
    The protein encoded by this gene is a member of the cyclin-dependent serine/threonine protein kinase family. Members of this family are well known for their essential roles as master switches in cell cycle control. Some of the cell cycle control kinases are able to phosphorylate proteins that are important for cell differentiation and apoptosis, thus provide connections between cell proliferation, differentiation, and apoptosis. Proteins of this family may also be involved in non-cell cycle-related functions, such as neurocytoskeleton dynamics. The exact function of this protein has not yet been determined. It has unusually large N- and C-termini and is ubiquitously expressed in many tissues. Two alternatively spliced variants are described. [provided by RefSeq]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Topography of transcriptionally active chromatin in glioblastoma. Xu L et al., 2021 Apr, Sci Adv
    Read more
  • CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling. Choi HJ et al., 2019 Oct 4, EMBO Rep
    Read more